# Bet Cell Therapy in Diabetes Type 1

> **NCT01379729** · PHASE2 · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 10 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **OTHER:** Transplantation of encapsulated beta cells.
- **OTHER:** Transplantation of encapsulated beta cells.

## Key facts

- **NCT ID:** NCT01379729
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-05
- **Primary completion:** 2013-12
- **Final completion:** 2018-05
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2013-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01379729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01379729, "Bet Cell Therapy in Diabetes Type 1". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01379729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*